Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen

EMBO Reports
Terrie-Anne CockJ Auwerx

Abstract

The peroxisome proliferator-activated receptor gamma (PPARgamma) controls adipogenesis and metabolism. We demonstrate here that the absence of PPARgamma in fat has potent osteogenic activities, which affect haematopoiesis. The congenital absence of PPARgamma in fat of lipodystrophic PPARgamma(hyp/hyp) mice, strongly enhanced bone mass and consequentially reduced the bone-marrow cavity. Consistent with this, PPARgamma(hyp/hyp) mice had a significant decrease in bone marrow cellularity and resorted to extramedullary haematopoiesis in the spleen to maintain haematopoiesis. Our data indicate that antagonizing PPARgamma activity in fat could be an effective way to combat osteoporosis and suggest that haematopoietic function should be scrutinized in lipodystrophic subjects.

References

Nov 1, 1981·American Journal of Hematology·M H Freedman, E F Saunders
Feb 2, 1995·The New England Journal of Medicine·S C Manolagas, R L Jilka
Jan 1, 1995·Clinical Nuclear Medicine·C CaluserH Kalaigian
Sep 1, 1996·Current Biology : CB·B D BennettW Matthews
Oct 24, 1998·Genes & Development·J MoitraC Vinson
Jul 21, 1999·Journal of Cellular Biochemistry·B Lecka-CzernikR L Jilka
Jun 11, 2002·Annual Review of Nutrition·Frédéric Picard, Johan Auwerx
Jul 13, 2002·American Journal of Medical Genetics·Anna RajabMichael Patton
Nov 7, 2002·Cell·Shu TakedaGerard Karsenty
May 16, 2003·Nature·Shun-ichi Harada, Gideon A Rodan
Sep 23, 2003·Endocrinology·S O RzoncaB Lecka-Czernik
Oct 24, 2003·Nature·L M CalviD T Scadden
Nov 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hana KoutnikovaJohan Auwerx
Jan 13, 2004·Science·Robert F KleinEric S Orwoll
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·F ElefteriouG Karsenty

❮ Previous
Next ❯

Citations

Apr 19, 2007·Calcified Tissue International·M S Patel, F Elefteriou
Jun 28, 2005·Journal of Bone and Mineral Metabolism·Hiroshi KawaguchiKozo Nakamura
Nov 24, 2006·Reviews in Endocrine & Metabolic Disorders·Hiroshi Kawaguchi
Apr 29, 2010·Current Osteoporosis Reports·Beata Lecka-Czernik
Jun 6, 2009·Nature Medicine·Charlotte Schubert
Dec 7, 2007·Nature Medicine·Yihong WanRonald M Evans
May 27, 2009·Nature Reviews. Rheumatology·Masanobu KawaiClifford J Rosen
May 31, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Susan C YanikJennifer J Schlezinger
Aug 2, 2008·Diabetes, Obesity & Metabolism·Andrew Grey
May 15, 2012·Science·Carles Cantó, Johan Auwerx
Mar 28, 2009·PPAR Research·Eoin J CotterPeter P Doran
Mar 3, 2007·Endocrinology·Oxana P LazarenkoBeata Lecka-Czernik
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Christina N BennettOrmond A MacDougald
Feb 22, 2008·PPAR Research·K R ShockleyB Lecka-Czernik
Jan 15, 2013·PPAR Research·Ichiro TakadaShigeaki Kato
Nov 28, 2012·Cellular and Molecular Life Sciences : CMLS·H Sadie-Van GijsenW F Ferris
Apr 2, 2013·Clinical Reviews in Bone and Mineral Metabolism·Beata Lecka-Czernik
Jan 25, 2007·Expert Opinion on Investigational Drugs·Costas GiaginisStamatios Theocharis
Jan 26, 2005·European Journal of Clinical Investigation·C A ArgmannJ Auwerx
Apr 20, 2013·International Immunopharmacology·Marcelo Henrique NapimogaElizabeth Ferreira Martinez
Jan 30, 2007·PPAR Research·Beata Lecka-Czernik, Larry J Suva
Oct 5, 2010·Cell Cycle·Beata Lecka-CzernikMasanobu Kawai
Apr 16, 2015·International Journal of Endocrinology·Amélie E CoudertAndrea Del Fattore
May 26, 2016·Scientific Reports·Ya-Hui LiuPei-Jane Tsai
Nov 9, 2016·Frontiers in Endocrinology·Ana María PinoClifford J Rosen
Aug 26, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xue-Dong LiShi-Xin Du
Apr 29, 2009·Expert Opinion on Therapeutic Targets·Ichiro TakadaShigeaki Kato
Feb 12, 2008·Current Protocols in Molecular Biology·Carmen A ArgmannJohan Auwerx
Feb 16, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Jun-Ming HuangFeng-Jin Guo
Jun 11, 2015·Journal of Cellular Physiology·Robrigo P F AbunaMarcio M Beloti
Sep 15, 2006·Journal of Cellular Physiology·Sergiu Botolin, Laura R McCabe
Mar 14, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J Ignacio AguirreThomas J Wronski
Nov 3, 2007·Journal of Cellular Biochemistry·Laura R McCabe
Jul 8, 2008·Journal of Neuroendocrinology·S Takeda
Feb 16, 2006·Journal of Cellular Biochemistry·Jeffrey M GimbleMark E Nuttall
Dec 31, 2014·Molecular Endocrinology·Zixue JinYihong Wan
May 1, 2009·Expert Review of Endocrinology & Metabolism·Laura R McCabe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.